CONFIDENTIAL — APPROVED FOR PUBLIC RELEASE · BUREAU FILE COPY RECORDS CURRENT AS OF 29 MAY 2026 · DISTRIBUTION: UNRESTRICTED
VendorInvestigator Independent Testing Bureau · Public Records Division
DOCKET YEAR 2026 · VOL. II
35,156 SAMPLES ON FILE
No fee · No favor
Compound Evidence File
#EC-2026-0101

Trenbolone Acetate Raw

Filed under Raw Materials. The bureau holds 133 laboratory returns for this compound from 38 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.

Cross-Index

Subjects Shipping This Compound

38 SUBJECTS
SubjectGradeSamplesMeanMinMaxFirst seenLast seen
HomopeptideCASE #VI-2026-0760 A 4 10.0 9.9 10.0 24 May 2026 24 May 2026
Tianjin Finder Chemical TFCCASE #VI-2026-0693 A 4 10.0 9.9 10.0 14 Nov 2025 16 Apr 2026
QYAOBIOCASE #VI-2026-0861 A 4 10.0 10.0 10.0 2 May 2026 10 Jul 2026
BachemCASE #VI-2026-0314 A 4 10.0 9.9 10.0 23 Dec 2025 7 Jul 2026
Kerui PeptidesCASE #VI-2026-0626 A 4 10.0 9.9 10.0 14 Nov 2025 10 Jul 2026
WuXi TIDESCASE #VI-2026-0335 A 4 10.0 9.9 10.0 5 Mar 2026 18 Jun 2026
PolyPeptide GroupCASE #VI-2026-0143 A 4 10.0 10.0 10.0 24 Mar 2026 8 Aug 2026
Hubei JianxiangCASE #VI-2026-0048 A 3 10.0 10.0 10.0 24 May 2026 26 Jun 2026
Chinese Peptide CompanyCASE #VI-2026-0184 A 3 10.0 10.0 10.0 11 Feb 2026 8 Apr 2026
GenScript PeptidesCASE #VI-2026-0860 A 3 10.0 10.0 10.0 6 Jul 2026 8 Aug 2026
Thermo Fisher ScientificCASE #VI-2026-0142 A 3 10.0 9.9 10.0 18 Feb 2026 14 Aug 2026
SinoPepCASE #VI-2026-0387 A 3 10.0 10.0 10.0 8 May 2026 4 Aug 2026
AmbioPharmCASE #VI-2026-0177 A 3 10.0 10.0 10.0 16 Mar 2026 16 Aug 2026
Sangon BioCASE #VI-2026-0671 A 2 10.0 10.0 10.0 12 Jun 2026 3 Jul 2026
JEEP PeptidesCASE #VI-2026-0457 A 4 9.9 9.9 10.0 3 Jan 2026 7 Jul 2026
Flourishglobal PeptideCASE #VI-2026-0630 A 4 9.9 9.9 10.0 5 Apr 2026 23 May 2026
Shanghai Wibson BiotechnologyCASE #VI-2026-0379 A 3 9.9 9.9 9.9 2 Mar 2026 6 Jul 2026
Shanghai ERP BiotechnologyCASE #VI-2026-0936 A 2 9.9 9.9 9.9 24 Mar 2026 12 Jun 2026
Mokemei BiotechnologyCASE #VI-2026-0540 A 2 9.9 9.9 10.0 4 Apr 2026 8 Jul 2026
Shanghai Sigma AudleyCASE #VI-2026-0505 A 2 9.9 9.9 10.0 2 Jun 2026 8 Jul 2026
Hybio PharmaceuticalCASE #VI-2026-0065 A 2 9.9 9.9 10.0 24 Dec 2025 9 Aug 2026
Sigma-AldrichCASE #VI-2026-0829 A 2 9.9 9.9 9.9 2 Jul 2026 2 Jul 2026
AsymchemCASE #VI-2026-0091 A 2 9.9 9.9 10.0 4 Jun 2026 27 Jul 2026
Qingdao Sigma Chemical QSCCASE #VI-2026-0538 A 8 8.8 6.0 10.0 25 May 2026 25 May 2026
Glbiochem (Shanghai)CASE #VI-2026-0704 A 8 8.3 7.0 9.6 24 May 2026 24 May 2026
OmegAminoCASE #VI-2026-0014 X 1 8.3 8.3 8.3 3 Jul 2025 3 Jul 2025
Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 A 4 8.2 6.8 9.5 21 May 2026 21 May 2026
Shanghai Sigma Audley SSACASE #VI-2026-0486 A 6 8.0 6.0 10.0 23 May 2026 23 May 2026
Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 A 7 7.9 7.4 8.4 24 May 2026 24 May 2026
YimeiCASE #VI-2026-0081 X 5 7.4 6.7 8.1 17 Dec 2024 21 May 2026
NexaphCASE #VI-2026-0944 X 15 6.7 3.1 9.6 2 Jul 2025 19 Jan 2026
Forever Young PharmacyCASE #VI-2026-0654 X 2 6.2 4.2 8.2 14 Jan 2025 26 Jan 2026
Oasis PeptidesCASE #VI-2026-0404 X 1 6.2 6.2 6.2 3 Jul 2025 3 Jul 2025
Zenith Jove Peptide ZJCASE #VI-2026-0570 X 1 5.9 5.9 5.9 9 Jun 2025 9 Jun 2025
Richards Biotech Simply RichardsCASE #VI-2026-0307 X 1 5.8 5.8 5.8 2 Apr 2025 2 Apr 2025
Hunan Ruiwang Technology CenterCASE #VI-2026-0027 X 1 5.4 5.4 5.4 16 Mar 2025 16 Mar 2025
Qingdao VitaConin International TradingCASE #VI-2026-0504 X 1 4.8 4.8 4.8 11 Jun 2025 11 Jun 2025
Alimo PeptideCASE #VI-2026-0524 X 1 3.9 3.9 3.9 14 Jan 2025 14 Jan 2025

Open any subject to view the batch-level evidence for Trenbolone Acetate Raw alone.